Oncology PracticeResearchers share Nobel Prize for cancer immunotherapy discoveriesOctober 1, 2018Immuno-oncologyMixed Topics
Oncology PracticeEndogenous retroviruses may unlock new immunotherapy targetsSeptember 28, 2018Immuno-oncology
Oncology PracticePACIFIC trial: Durvalumab improves both OS and PFS in stage III NSCLCSeptember 28, 2018Immuno-oncologyLung Cancer
Hematology NewsCAR T-cell studies dominate ongoing cellular therapy trialsSeptember 26, 2018Cellular TherapyAggressive LymphomasImmuno-oncologyLymphoma & Plasma Cell DisordersB Cell Lymphoma
Oncology PracticeDramatic response from pembrolizumab in patient with Lynch syndromeSeptember 24, 2018Immuno-oncologyGynecologic CancerGastroenterologyGastrointestinal Cancer
Oncology PracticePD-1/PD-L1 treatment linked to hyperprogressive disease in lung cancer patientsSeptember 20, 2018Immuno-oncologyLung Cancer
Oncology PracticeFatal toxicities from checkpoint inhibitors vary by agentSeptember 19, 2018Immuno-oncologyMelanomaLung Cancer
Hematology NewsKymriah cost effectiveness depends on long-term outcomesSeptember 17, 2018ALLBusiness of MedicineCellular TherapyPractice ManagementImmunotherapyImmuno-oncologyB Cell Lymphoma
Oncology PracticeSkin signs may be good omens during cancer therapySeptember 13, 2018Nonmelanoma Skin CancerImmuno-oncologyPatient & Survivor CareMelanoma
Oncology PracticeHIV-associated Kaposi sarcoma responds to checkpoint inhibitorsSeptember 7, 2018Immuno-oncologySarcoma & GIST
Oncology PracticePD1 mRNA may predict response to anti-PD1 monotherapy across cancer typesSeptember 4, 2018Immuno-oncologyMelanomaLung CancerRenal Cell Carcinoma
Oncology PracticeCAR T coverage: Drugmakers say no to patient reported outcomesAugust 30, 2018Practice ManagementBusiness of MedicineImmuno-oncologyCellular Therapy
Oncology PracticeNivolumab plus ipilimumab effective in melanoma brain metastasesAugust 27, 2018MelanomaCNS/Brain CancerImmuno-oncology
Oncology PracticeAdding checkpoint inhibitors to radiotherapy requires particular caution in this one scenarioAugust 24, 2018Immuno-oncologyLung CancerCNS/Brain CancerMelanoma
Oncology PracticeBaseline steroids may reduce efficacy of checkpoint inhibitorsAugust 24, 2018Lung CancerImmuno-oncology
